Related by context. Frequent words. (Click for all words.) 79 label dose escalation 71 multicenter 71 multicenter randomized double 69 multicentre 69 prospective randomized 69 randomized controlled 69 multicenter clinical 69 randomized Phase III 67 randomized 67 blind randomized 66 placebo controlled 66 randomized placebo controlled 65 randomized double 65 dose escalation trial 65 Phase 2b study 64 blind randomized placebo 64 Phase 1b clinical 64 phase IIa 64 double blind placebo 64 dose escalation study 63 Phase 2a clinical 63 randomized controlled clinical 63 phase IIb 62 randomized #:# 62 randomized Phase 62 randomized clinical 62 safety tolerability pharmacokinetics 62 Phase 2b clinical 62 Phase Ib 61 Phase IIa clinical 61 Phase III pivotal 61 Phase 2a trial 61 Phase IIa trial 61 blinded placebo controlled 61 blind placebo controlled 61 Phase 1b 61 confirmatory Phase III 61 Phase IIb clinical 60 dabigatran etexilate 60 pivotal Phase III 60 Phase 2b 60 Phase III clinical 60 multicenter study 60 pivotal Phase 60 Phase IIb trial 60 Phase IIa 60 Randomized 60 noninferiority 59 Phase IIb 59 Phase 2a 59 Phase 2b trial 59 Phase 1b trial 59 dose escalation 58 ACTEMRA 58 unblinded 58 phase 2a 58 pharmacodynamics 58 dose cohorts 57 TELCYTA 57 substudy 57 relapsed multiple myeloma 57 mg BID 57 non inferiority 57 Stent System 57 Phase 1a 57 Phase Ia 57 single ascending dose 57 Completes Enrollment 57 randomized controlled trial 57 Phase III 57 SPIRIT III 56 Investigational Device Exemption IDE 56 CYPHER ® Stent 56 multiple ascending dose 56 clinical trial 56 Phase III Trial 56 diabetic neuropathic pain 55 investigational oral 55 CYPHER R Stent 55 tolerability 55 events AEs 55 dose regimens 55 BAY #-# 55 Board DSMB 55 PROMACTA 55 bosentan 54 evaluable patients 54 placebo controlled trials 54 Phase II 54 ThermoDox ® 54 Clinical Study 54 Phase III clinical trials 54 vicriviroc 54 valopicitabine 54 6R BH4 54 confirmatory Phase 3 54 safety tolerability 54 HGS ETR1 54 Monotherapy 54 LEVADEX 54 everolimus